In Memoriam

In memoriam: Michael Waterfield

Swarnali  Roy
May 6, 2024

Michael Derek Waterfield, a British biochemist and a pioneer in the cancer research field died on May 11, 2023, at the age of 82, the American Society for Biochemistry and Molecular Biology learned recently. He had been an ASBMB member since 1996. 

Portrait of Michael Waterfield
Michael Waterfield

Born in Hampshire, United Kingdom on May 14, 1941, Waterfield completed his undergraduate studies in biochemistry at Brunel University, London. He then earned his Ph.D. in protein chemistry and enzymology from King’s College Hospital Medical School, London. He moved to Harvard Medical School in 1967 to pursue postdoctoral studies in which he quantified the method of sequential degradation of proteins and peptides. 

Following a second postdoctoral stint with American biologist Leroy Hood at the California Institute of Technology on first gas phase protein sequencer and upon receiving a fellowship from the American Heart Foundation, Waterfield joined the Imperial Cancer Research Fund, or ICRF, in London in 1972. His research group and technical team at ICRF were the first to implement a first-generation state-of-the-art protein sequence database. 

Waterfield developed his interest in studying growth factor receptors. Using highly purified fibroblast‐derived growth factor, or FDGF, he reported a structural resemblance between platelet‐derived growth factor and FDGF. His group also found the relationship between epidermal growth factor receptor, or EGFR, and oncogenes and was the first to sequence protein kinase C. Waterfield was instrumental in groundbreaking cancer research in ICRF, and his findings led to development of anti-cancer drugs targeting the EGF receptor family. 

In 1986, Waterfield joined the Ludwig Institute for Cancer Research at University College London as director. He developed his interest in the critical growth regulatory enzyme phosphatidylinositol 3-kinase, or PI3K, and started working on its sequence. He also founded a biotech company Piramed where six drugs targeting PI3K enzymes were clinically approved. 

Waterfield had more than 151 publications in journals such as Nature, Science, and the Journal of Biological Chemistry, with more than 39,352 citations. He also broadened research horizons in cancer proteomics by opening a proteomics lab at University College London. He retired in 2008. 

Waterfield was a fellow of the Royal Society, the Royal College of Pathologists and the Academy of Medical Sciences U.K.  He was recognized with the Royal Society's Buchanan Medal in 2002 for his exceptional skill in protein biochemistry and the Biology and Biochemistry in Belgium Leader Award in 2023. 

He is survived by his wife, Sal, and his daughters, Lucy and Rosie.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Swarnali  Roy

Swarnali Roy is a postdoctoral researcher in the Laboratory of Bioorganic Chemistry at the National Institute of Diabetes and Digestive and Kidney Diseases. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Meet Lan Huang
Interview

Meet Lan Huang

May 19, 2025

Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Meet Shannon Reilly
Profile

Meet Shannon Reilly

May 12, 2025

The JLR junior associate editor discusses the role of adipocytes in obesity at Weill Cornell Medical School.

Meet Donita Brady
Interview

Meet Donita Brady

May 8, 2025

Donita Brady is an associate professor of cancer biology and an associate editor of the Journal of Biological Chemistry, who studies metalloallostery in cancer.

Glyco get-together exploring health and disease
Interview

Glyco get-together exploring health and disease

May 7, 2025

Meet the co-chairs of the 2025 ASBMB meeting on O-GlcNAcylation to be held July 10–13, 2025, in Durham, North Carolina. Learn about the latest in the field and meet families affected by diseases associated with this pathway.

ASBMB recognizes 2025 outstanding student chapter
Student Chapters

ASBMB recognizes 2025 outstanding student chapter

May 6, 2025

The Purdue group, led by Orla Hart, developed STEM outreach initiatives for low-income and minority students in Lafayette, Indiana.

ASBMB inducts 2025 honor society members
Student Chapters

ASBMB inducts 2025 honor society members

May 5, 2025

Chi Omega Lambda, which recognizes exceptional juniors and seniors pursuing degrees in the molecular life sciences, has 16 new inductees in 2025.